These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 22659593)
1. Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases. Merz M; Komljenovic D; Semmler W; Bäuerle T Invest Radiol; 2012 Jul; 47(7):422-9. PubMed ID: 22659593 [TBL] [Abstract][Full Text] [Related]
2. Drug-induced vessel remodeling in bone metastases as assessed by dynamic contrast enhanced magnetic resonance imaging and vessel size imaging: a longitudinal in vivo study. Bäuerle T; Merz M; Komljenovic D; Zwick S; Semmler W Clin Cancer Res; 2010 Jun; 16(12):3215-25. PubMed ID: 20530698 [TBL] [Abstract][Full Text] [Related]
3. Imaging anti-angiogenic treatment response with DCE-VCT, DCE-MRI and DWI in an animal model of breast cancer bone metastasis. Bäuerle T; Bartling S; Berger M; Schmitt-Gräff A; Hilbig H; Kauczor HU; Delorme S; Kiessling F Eur J Radiol; 2010 Feb; 73(2):280-7. PubMed ID: 19070445 [TBL] [Abstract][Full Text] [Related]
4. Multi-modal imaging of angiogenesis in a nude rat model of breast cancer bone metastasis using magnetic resonance imaging, volumetric computed tomography and ultrasound. Bäuerle T; Komljenovic D; Berger MR; Semmler W J Vis Exp; 2012 Aug; (66):e4178. PubMed ID: 22929330 [TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted imaging and dynamic contrast-enhanced MRI of experimental breast cancer bone metastases--a correlation study with histology. Merz M; Seyler L; Bretschi M; Semmler W; Bäuerle T Eur J Radiol; 2015 Apr; 84(4):623-30. PubMed ID: 25641009 [TBL] [Abstract][Full Text] [Related]
6. Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI. Bäuerle T; Hilbig H; Bartling S; Kiessling F; Kersten A; Schmitt-Gräff A; Kauczor HU; Delorme S; Berger MR Neoplasia; 2008 May; 10(5):511-20. PubMed ID: 18472968 [TBL] [Abstract][Full Text] [Related]
7. Cilengitide inhibits metastatic bone colonization in a nude rat model. Bretschi M; Merz M; Komljenovic D; Berger MR; Semmler W; Bäuerle T Oncol Rep; 2011 Oct; 26(4):843-51. PubMed ID: 21725616 [TBL] [Abstract][Full Text] [Related]
8. Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study. Bäuerle T; Komljenovic D; Merz M; Berger MR; Goodman SL; Semmler W Int J Cancer; 2011 May; 128(10):2453-62. PubMed ID: 20648558 [TBL] [Abstract][Full Text] [Related]
9. Morphological, functional, and molecular assessment of breast cancer bone metastases by experimental ultrasound techniques compared with magnetic resonance imaging and histological analysis. Heinen H; Seyler L; Popp V; Hellwig K; Bozec A; Uder M; Ellmann S; Bäuerle T Bone; 2021 Mar; 144():115821. PubMed ID: 33348127 [TBL] [Abstract][Full Text] [Related]
10. Cilengitide affects tumor compartment, vascularization and microenvironment in experimental bone metastases as shown by longitudinal ¹⁸F-FDG PET and gene expression analysis. Bretschi M; Cheng C; Witt H; Dimitrakopoulou-Strauss A; Strauss LG; Semmler W; Bäuerle T J Cancer Res Clin Oncol; 2013 Apr; 139(4):573-83. PubMed ID: 23229276 [TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts. Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441 [TBL] [Abstract][Full Text] [Related]
12. Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer. Gaeta M; Benedetto C; Minutoli F; D'Angelo T; Amato E; Mazziotti S; Racchiusa S; Mormina E; Blandino A; Pergolizzi S Acad Radiol; 2014 Oct; 21(10):1286-93. PubMed ID: 25088834 [TBL] [Abstract][Full Text] [Related]
13. MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer. Preda A; Novikov V; Möglich M; Turetschek K; Shames DM; Brasch RC; Cavagna FM; Roberts TP J Magn Reson Imaging; 2004 Nov; 20(5):865-73. PubMed ID: 15503324 [TBL] [Abstract][Full Text] [Related]
14. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902 [TBL] [Abstract][Full Text] [Related]
15. Assessing treatment response of osteolytic lesions by manual volumetry, automatic segmentation, and RECIST in experimental bone metastases. Bretschi M; Fränzle A; Merz M; Hillengass J; Semmler W; Bendl R; Bäuerle T Acad Radiol; 2014 Sep; 21(9):1177-84. PubMed ID: 24998693 [TBL] [Abstract][Full Text] [Related]
16. Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model. Wang H; Hristov D; Qin J; Tian L; Willmann JK Radiology; 2015 Nov; 277(2):424-34. PubMed ID: 26020439 [TBL] [Abstract][Full Text] [Related]
17. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption. Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090 [TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation of experimental bone metastases in nude rats. Proschek D; Mack MG; Kurth AA; Proschek P; Martin B; Hansmann ML; Vogl TJ Anticancer Res; 2008; 28(2A):879-85. PubMed ID: 18507032 [TBL] [Abstract][Full Text] [Related]
19. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging. Ricci P; Cantisani V; Ballesio L; Pagliara E; Sallusti E; Drudi FM; Trippa F; Calascibetta F; Erturk SM; Modesti M; Passariello R Ultraschall Med; 2007 Feb; 28(1):57-62. PubMed ID: 17304413 [TBL] [Abstract][Full Text] [Related]
20. MR monitoring of cyclooxygenase-2 inhibition of angiogenesis in a human breast cancer model in rats. Fournier LS; Novikov V; Lucidi V; Fu Y; Miller T; Floyd E; Shames DM; Brasch RC Radiology; 2007 Apr; 243(1):105-11. PubMed ID: 17329684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]